OrthoPediatrics Corp (KIDS) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 52.85M USD | Liabilities, Current |
| Cash and equivalents | 17.00M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 60.95M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 137.57M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $52.85M | $17.00M | (m) | $60.95M | $137.57M | (m) |
| 2026-03-31 | (m) | $47.18M | $12.19M | (m) | $54.43M | $134.02M | (m) |
| 2025-12-31 | (m) | $46.20M | $19.56M | (m) | $53.84M | $133.79M | (m) |
| 2025-09-30 | (m) | $33.23M | $16.83M | (m) | $51.27M | $128.81M | (m) |
| 2025-06-30 | (m) | $38.67M | $44.55M | (m) | $53.80M | $125.27M | (m) |
| 2025-03-31 | (m) | $37.51M | $33.44M | (m) | $43.99M | $119.75M | (m) |
| 2024-12-31 | (m) | $33.96M | $43.82M | (m) | $42.36M | $117.00M | (m) |
| 2024-09-30 | (m) | $34.63M | $51.05M | (m) | $42.83M | $120.93M | (m) |
| 2024-06-30 | (m) | $39.57M | $28.93M | (m) | $42.03M | $116.37M | (m) |
| 2024-03-31 | (m) | $45.82M | $21.60M | (m) | $36.27M | $112.69M | (m) |
| 2023-12-31 | (m) | $41.67M | $31.05M | (m) | $34.62M | $105.85M | (m) |
| 2023-09-30 | (m) | $47.93M | $10.64M | (m) | $37.65M | $100.53M | (m) |
| 2023-06-30 | (m) | $44.31M | $9.71M | (m) | $33.85M | $90.98M | (m) |
| 2023-03-31 | (m) | $35.22M | $34.66M | (m) | $26.84M | $84.92M | (m) |
| 2022-12-31 | (m) | $30.87M | (m) | (m) | $24.80M | $78.19M | (m) |
| 2022-09-30 | (m) | $28.75M | (m) | (m) | $26.18M | $74.04M | (m) |
| 2022-06-30 | (m) | $31.21M | $37.20M | (m) | $25.43M | $67.48M | (m) |
| 2022-03-31 | (m) | $34.33M | $17.96M | (m) | $17.91M | $64.08M | (m) |
| 2021-12-31 | (m) | $29.71M | $7.64M | (m) | $17.94M | $57.57M | (m) |
| 2021-09-30 | (m) | $28.02M | $6.33M | (m) | $18.15M | $55.46M | (m) |
| 2021-06-30 | (m) | $30.33M | $10.56M | (m) | $19.22M | $56.38M | (m) |
| 2021-03-31 | (m) | $36.62M | $21.43M | (m) | $16.55M | $55.27M | (m) |
| 2020-12-31 | (m) | $35.03M | $28.76M | (m) | $17.21M | $52.99M | (m) |
| 2020-09-30 | (m) | $25.75M | $88.37M | (m) | $17.06M | $52.03M | (m) |
| 2020-06-30 | (m) | $24.77M | $113.05M | (m) | $14.90M | $48.88M | (m) |
| 2020-03-31 | (m) | $13.83M | $53.58M | (m) | $14.12M | $43.97M | (m) |
| 2019-12-31 | (m) | $13.66M | $70.78M | (m) | $16.00M | $38.00M | (m) |
| 2019-09-30 | (m) | $46.18M | (m) | (m) | $14.18M | $34.53M | (m) |
| 2019-06-30 | (m) | $42.19M | (m) | (m) | $14.97M | $32.85M | (m) |
| 2019-03-31 | (m) | $10.82M | (m) | (m) | $10.30M | $28.08M | (m) |
| 2018-12-31 | (m) | $9.22M | $60.69M | (m) | $9.00M | (m) | (m) |
| 2018-09-30 | (m) | $10.92M | $24.46M | (m) | $9.46M | (m) | (m) |
| 2018-06-30 | (m) | $10.49M | $26.51M | (m) | $9.76M | (m) | (m) |
| 2018-03-31 | (m) | $10.57M | $34.59M | (m) | $6.84M | (m) | (m) |
| 2017-12-31 | (m) | $9.47M | $42.58M | (m) | $5.60M | (m) | (m) |
| 2017-09-30 | (m) | $10.42M | $2.24M | (m) | $5.69M | (m) | (m) |
| 2017-06-30 | (m) | (m) | $2.31M | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | $2.45M | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $7.25M | $1.61M | (m) | $4.10M | (m) | (m) |
| 2016-09-30 | (m) | (m) | $1.31M | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | $3.88M | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | $6.58M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| CARLSMED, INC. (CARL) | United States | $0.405B |